A COMbined progRamme of Exercise and Dietary ADvice in mEn With Castrate Resistant Prostate Cancer
NCT03017417 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31
Last updated 2024-07-18
Summary
The proposed study will assess the feasibility of an exercise and dietary intervention in men with castrate resistant prostate cancer with secondary outcomes assessing improvements in physical functioning, fatigue, quality of life, and body composition.The study will have 2 arms, with one set of participants randomized to resistance exercise training intervention plus dietary advice and the other arm will be standard of care plus exercise advice.
Conditions
- Prostatic Neoplasms, Castration-Resistant
- Prostate Cancer
Interventions
- OTHER
-
Exercise Intervention
Various exercise tests
- OTHER
-
standard of care
standard treatment
Sponsors & Collaborators
-
Sheffield Hallam University
collaborator OTHER -
Sheffield Teaching Hospitals NHS Foundation Trust
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-02-08
- Primary Completion
- 2018-12-31
- Completion
- 2018-12-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Multicenter Study Comparing Taxotere Plus Curcumin Versus Taxotere Plus Placebo Combination in First-line Treatment of Prostate Cancer Metastatic Castration Resistant (CURTAXEL)
NCT02095717 ·Status: TERMINATED ·Phase: PHASE2
-
Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate Cancer
NCT00669162 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Androgen Deprivation Therapy on Cardiovascular Function in Prostate Cancer
NCT03275181 ·Status: COMPLETED
-
Exercise Prescription Dose for Castration Resistance Prostate Cancer Patients
NCT03526562 ·Status: COMPLETED ·Phase: NA
-
Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer
NCT00104715 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer
NCT05156424 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy
NCT01410942 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Exercise Intervention for Pts With Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone or Enzalutamide
NCT02130947 ·Status: WITHDRAWN ·Phase: NA
-
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
NCT03127631 ·Status: RECRUITING ·Phase: NA
-
Exercise Training as a Novel Primary Therapy for Men With Localised Prostate Cancer
NCT02409212 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial of Androgen Deprivation, Docetaxel, and Enzalutamide for Metastatic Prostate Cancer
NCT03246347 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
CytoREductive prostAtectomy for Poly-metastatic Hormone sensiTIVE Prostate Cancer
NCT06306612 ·Status: RECRUITING ·Phase: NA
-
Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients
NCT03987217 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma
NCT03436654 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer
NCT00170157 ·Status: COMPLETED ·Phase: PHASE2
-
Metastasis-directed Therapy for Oligorecurrent Prostate Cancer
NCT05352178 ·Status: RECRUITING ·Phase: PHASE3
-
INTERVAL - Intense Exercise Trial for Men With Metastatic Castrate-Resistant Prostate Cancer
NCT04507698 ·Status: UNKNOWN ·Phase: NA
-
ABT-751 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
NCT00471718 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Quality of Life in Patients Undergoing Surgery or Brachytherapy for Stage II Prostate Cancer
NCT00052481 ·Status: COMPLETED
-
RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local Surgery
NCT00541047 ·Status: COMPLETED ·Phase: PHASE3
-
Neoadjuvant Androgen Deprivation, Darolutamide, and Ipatasertib in Men With Localized, High Risk Prostate Cancer
NCT04737109 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Pilot Trial of Chemohormonal Therapy Followed by Prostatectomy in High Risk Prostate Cancer
NCT03358563 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Androgen Deprivation Therapy Combined With Docetaxel for High Risk Prostate Cancer
NCT04869371 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.
NCT03971110 ·Status: TERMINATED ·Phase: PHASE4
-
A Pilot Study of Exercise in Patients With Docetaxel-Based Chemotherapy for Hormone Refractory Prostate Cancer
NCT00271687 ·Status: COMPLETED ·Phase: PHASE2